Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug:185:88-90.
doi: 10.1016/j.puhe.2020.06.006. Epub 2020 Jun 11.

Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers

N Kumleben  1 , R Bhopal  2 , T Czypionka  3 , L Gruer  4 , R Kock  5 , J Stebbing  6 , F L Stigler  7
Affiliations

Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers

N Kumleben et al. Public Health. 2020 Aug.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody tests of varying specificity and sensitivity are now available. For informing individuals whether they have had coronavirus disease 2019 (COVID-19), they need to be very accurate. For measuring population prevalence of past infection, the numbers of false positives and negatives need to be roughly equal. With a series of worked examples for a notional population of 100,000 people, we show that even test systems with a high specificity can yield a large number of false positive results, especially where the population prevalence is low. For example, at a true population prevalence of 5%, using a test with 99% sensitivity and specificity, 16% of positive results will be false and thus 950 people will be incorrectly informed they have had the infection. Further confirmatory testing may be needed. Giving false reassurance on which personal or societal decisions might be based could be harmful for individuals, undermine public confidence and foster further outbreaks.

Keywords: Antibody tests; COVID-19; Sensitivity; Specificity.

PubMed Disclaimer

References

    1. Watson J., Whiting P.F., Brush J.E. Interpreting a COVID-19 test result. BMJ. 2020;369:m1808. doi: 10.1136/bmj.m1808. - DOI - PubMed
    1. Horowitz J. In Italy, Going back to work may depend on having the right antibodies. https://www.nytimes.com/2020/04/04/world/europe/italy-coronavirus-antibo... New York Times.
    1. Forgey Q. Fauci: coronavirus immunity cards for Americans are 'being discussed' Politico. https://www.politico.com/news/2020/04/10/fauci-coronavirus-immunity-card...
    1. Bhopal R. The burning building: recruiting recovered COVID-19 patients to the frontline by issuing certificates and offering voluntary registration. BMJ. 2020;368:m1101. - PubMed
    1. Public Health England Evaluation of Roche Elecsys Anti- SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 antibodies. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...

Substances